跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TISSUEBLUE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TISSUEBLUE
Authorized
STANDARD
TISSUEBLUE
dutch ophthalmic research center international bv
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
32e30d65a6a4d62e
Company
dutch ophthalmic research center international bv
Type
Standard
Approval Details
Approval Id
32e30d65a6a4d62e
Drug Approval Canada Name
TISSUEBLUE
Product Name
TISSUEBLUE
Status
Marketed
Status Date
2021-09-30
Original Market Date
2021-09-30
Din
02510995
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravitreal
Schedule
Prescription
Ahfs
36:58.00
Atc Original
S01K SURGICAL AIDS
Atc Name
s 01 k
Aig Number
0162723001
Company Name
dutch ophthalmic research center international bv
Company Address
Scheijdelveweg 2, Zuidland, Zuid-Holland, Netherlands, 3214 VN
Active Ingredients
BRILLIANT BLUE G
0.25 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
32e30d65a6a4d62e
Type
Standard
Back to Health Canada Approvals